CDC- BRFSS – ACBS 2021 Adult Prevalence Table 7

Table 7: Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 with current2 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2021.
State/Territory Current
Sample
size±
% SE§ 95% CI
Arizona 355 21.5 2.8 (16.0 – 27.0)
California 134 38.4 5.9 (26.8 – 50.0)
Connecticut 346 37.3 3.9 (29.7 – 44.9)
Florida 202 32.6 7.3 (18.3 – 46.9)
Georgia 232 33.7 4.5 (24.9 – 42.5)
Hawaii 176 24.0 4.7 (14.8 – 33.2)
Indiana 454 26.2 2.4 (21.5 – 30.9)
Iowa 289 28.6 3.4 (21.9 – 35.3)
Kansas 458 28.1 2.7 (22.8 – 33.4)
Kentucky 155 24.8 4.3 (16.4 – 33.2)
Maine 400 31.5 3.6 (24.4 – 38.6)
Maryland 342 26.8 3.1 (20.7 – 32.9)
Massachusetts 255 39.8 4.0 (32.0 – 47.6)
Michigan 509 29.6 2.5 (24.7 – 34.5)
Minnesota 494 27.1 2.4 (22.4 – 31.8)
Missouri 372 36.3 3.9 (28.7 – 43.9)
Montana 161 30.5 4.5 (21.7 – 39.3)
Nebraska 378 28.7 3.1 (22.6 – 34.8)
New Hampshire 399 29.1 3.1 (23.0 – 35.2)
New Jersey 283 30.8 3.8 (23.4 – 38.2)
New Mexico 215 27.6 4.1 (19.6 – 35.6)
New York 594 35.0 3.4 (28.3 – 41.7)
Ohio 364 27.1 3.2 (20.8 – 33.4)
Oregon 224 31.7 3.7 (24.4 – 39.0)
Pennsylvania 169 33.6 5.1 (23.6 – 43.6)
Rhode Island 346 33.5 3.3 (27.0 – 40.0)
Texas 338 31.5 4.4 (22.9 – 40.1)
Utah 345 27.6 3.0 (21.7 – 33.5)
Vermont 375 37.6 3.7 (30.3 – 44.9)
Wisconsin 293 38.5 4.3 (30.1 – 46.9)
30 States / Area 9,657 32.3 1.2 (29.9 – 34.7)
Median 30.7
Range 21.5-39.8

1 Aged ≥ 18 years

2 “Yes” response to “Do you still have asthma?”

± Sample size for adults with current asthma, excludes “DK/Refused”

§ Standard error

Confidence interval

Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2021/pdf/sdq_report_acbs_21-508.pdf